Roche’s FDA approval of Lunsumio VELO as a one-minute subcutaneous bispecific therapy for relapsed or refractory follicular ...

As trail hunting is set to be banned in England and Wales, hunt saboteurs and police officers discuss their ‘unlikely ...

Your support goes further this holiday season. When you buy an annual membership or give a one-time contribution, we’ll give a membership to someone who can’t afford access. It’s a simple way for you ...

KUALA LUMPUR, MY / ACCESS Newswire / December 21, 2025 / SumiSaujana Group Berhad ("SumiSaujana" or the "Company") and its subsidiary ("Group"), an established manufacturer of oil and gas ("O&G") ...

With several sites activated and recruitment ongoing, the Phase IIb trial is projected to deliver top-line outcomes next year ...

Peacekeepers in Ukraine will not be deployed until Europe begins to act independently of the United States — Ukrinform.

As Japan’s Cannabidiol (CBD) market resets under stricter regulations, a small number of global players are emerging with the scientific rigor and compliance needed to rebuild trust. One of them is ...

In this article, we examine ongoing challenges shaping target-based drug discovery and highlight how new technologies and interdisciplinary approaches are helping to address them.

KUALA LUMPUR, MY / ACCESS Newswire / December 21, 2025 / SumiSaujana Group Berhad ("SumiSaujana" or the "Company") and its subsidiary ("Group"), an established manufacturer of oil and gas ("O&G") spec ...

Archaeologists have confirmed that a vast planned settlement buried in the steppe of Kazakhstan is a lost Bronze Age city ...

The era of CureVac as an independent, publicly traded company has drawn to a close. BioNTech SE has successfully completed its takeover of the Tübingen-based ...

Gilead Sciences’ pre-exposure prophylaxis (PrEP) formula of lenacapavir has been approved in the UK as a preventative option ...